BioNTech financials at a glance

+ Portfolio

The revenue of BioNTech is reported as 4.19614 billion Dollars in the fiscal year 2023. The earnings were 4.27 Dollars per share in 2023, which was 4.69 lower than 2021. And about 6.10894 billion Dollars are reported as free cash flow in the financials of BioNTech 2023. No dividends were paid to the shareholders of the BioNTech stock NasdaqGS:BNTX in the financial year 2023.

$17.31B

Revenue

$37.77

Earnings Per Share

82.70%

Gross Margin %

$13.21B

Free Cash Flow

Revenue

17,310.60

Earnings Per Share

37.77

Gross Margin %

82.70

Free Cash Flow

13,214.10

Financials

Year	Year	TTM	2022	2021	2020	2019
Rev.	Revenue	N/A	$17.31B	$18.98B	$482.33M	$108.59M
GM %	Gross Margin %	90.87%	82.70%	84.66%	87.70%	83.98%
OM	Operating Margin	60.95%	68.83%	77.45%	-67.55%	-,167.13%
EPS	Earnings Per Share	$11.37	$37.77	$39.63	$0.06	$-0.85
Div.	Dividends	N/A	$0.00	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	0.00%	0.00%	0.00%	-0.00%
Sha.	Shares	N/AM	240.99M	242.52M	241.52M	226.78M
OCF	Operating Cash Flow	N/A	$13.58B	$889.70M	$-13.47M	$-,198.54M
FCF	Free Cash Flow	N/A	$13.21B	$735.70M	$-79.51M	$-,237.13M
FCFS	Free Cash Flow Per Share	$19.38	$54.31	$3.02	$-0.42	$-1.27

BioNTech financials at a glance

Financials

Discover